StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3011% above fair value
$262.21+2.61 (+1.01%)

Close on Nov 16, 2026Market cap $28.85BP/E 26.1Yield –

Quest Diagnostics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Quest Diagnostics's total debt was $5.55B at Sep 30, 2026. For fiscal 2025 it was $5.67B, down 8.8% from the year before. Over ten years it grew 4.5% a year on average. The highest annual figure on record is $6.22B in fiscal 2024.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.67B-8.8%
FY2024Dec 31, 2024$6.22B+31.9%
FY2023Dec 31, 2023$4.71B+18.4%
FY2022Dec 31, 2022$3.98B-0.8%
FY2021Dec 31, 2021$4.01B-0.1%
FY2020Dec 31, 2020$4.02B-15.8%
FY2019Dec 31, 2019$4.77B+22.5%
FY2018Dec 31, 2018$3.89B+2.9%
FY2017Dec 31, 2017$3.78B+1.3%
FY2016Dec 31, 2016$3.73B+2.3%
FY2015Dec 31, 2015$3.65B-2.4%
FY2014Dec 31, 2014$3.74B+12.3%
FY2013Dec 31, 2013$3.33B-1.0%
FY2012Dec 31, 2012$3.36B-16.4%
FY2011Dec 31, 2011$4.02B+34.6%
FY2010Dec 31, 2010$2.99B-3.8%
FY2009Dec 31, 2009$3.11B+0.8%
FY2008Dec 31, 2008$3.08B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$5.55B-2.2%
Q2 FY2026Jun 30, 2026$5.64B-0.5%
Q1 FY2026Mar 31, 2026$5.66B-3.4%
Q4 FY2025Dec 31, 2025$5.67B-8.8%
Q3 FY2025Sep 30, 2025$5.68B-9.2%
Q2 FY2025Jun 30, 2025$5.67B+28.3%
Q1 FY2025Mar 31, 2025$5.86B+24.4%
Q4 FY2024Dec 31, 2024$6.22B+31.9%
Q3 FY2024Sep 30, 2024$6.25B+47.1%
Q2 FY2024Jun 30, 2024$4.42B+3.0%
Q1 FY2024Mar 31, 2024$4.71B+18.4%
Q4 FY2023Dec 31, 2023$4.71B+18.4%
Q3 FY2023Sep 30, 2023$4.25B+6.7%
Q2 FY2023Jun 30, 2023$4.30B+7.8%
Q1 FY2023Mar 31, 2023$3.98B-0.3%
Q4 FY2022Dec 31, 2022$3.98B-0.8%
Q3 FY2022Sep 30, 2022$3.98B-0.6%
Q2 FY2022Jun 30, 2022$3.99B-0.6%
Q1 FY2022Mar 31, 2022$3.99B-0.6%
Q4 FY2021Dec 31, 2021$4.01B-0.1%
Q3 FY2021Sep 30, 2021$4.01B-12.4%
Q2 FY2021Jun 30, 2021$4.01B-12.3%
Q1 FY2021Mar 31, 2021$4.01B-0.6%
Q4 FY2020Dec 31, 2020$4.02B-15.8%
Q3 FY2020Sep 30, 2020$4.57B+14.5%
Q2 FY2020Jun 30, 2020$4.58B+15.1%
Q1 FY2020Mar 31, 2020$4.04B-4.8%
Q4 FY2019Dec 31, 2019$4.77B+22.5%
Q3 FY2019Sep 30, 2019$3.99B+8.0%
Q2 FY2019Jun 30, 2019$3.98B+7.1%
Q1 FY2019Mar 31, 2019$4.24B+9.8%
Q4 FY2018Dec 31, 2018$3.89B+2.9%
Q3 FY2018Sep 30, 2018$3.70B-1.8%
Q2 FY2018Jun 30, 2018$3.71B-0.6%
Q1 FY2018Mar 31, 2018$3.86B+3.4%
Q4 FY2017Dec 31, 2017$3.78B+1.3%
Q3 FY2017Sep 30, 2017$3.76B–
Q2 FY2017Jun 30, 2017$3.74B–
Q1 FY2017Mar 31, 2017$3.73B–
Q4 FY2016Dec 31, 2016$3.73B–

More Quest Diagnostics figures

See a number that looks wrong?